Pluri Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value
Pluri Inc. (PLUR) had Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value of $4.09 million as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue · last filed 2018-09-12
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $4.09M.
- 2017-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $869.00K.
- 2017-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $6.08M.
- 2016-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $2.22M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value |
|---|---|
| 2017-09-30 | $4.09M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $869.00K 10-K · filed 2018-09-12 |
| 2017-03-31 | $6.08M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $2.22M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $1.36M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $1.26M 10-K · filed 2017-09-07 |
| 2016-03-31 | $6.62M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $10.89M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $9.41M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $2.54M 10-K · filed 2016-09-07 |
| 2015-03-31 | $2.55M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $13.45M 10-Q · filed 2015-02-05 |
| 2014-09-30 | $2.34M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $851.00K 10-K · filed 2015-09-09 |
| 2014-03-31 | $1.62M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.45M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $4.12M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $5.12M 10-K · filed 2014-09-11 |
| 2012-06-30 | $4.13M 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |